The CAP called on federal policymakers to ensure patient safety when drafting a new artificial intelligence (AI) action plan, while also noting that pathologists must lead appropriate clinical decision-making.
On March 15, the CAP submitted comments on the White House Office of Science and Technology Policy (OSTP) Request for Information on the Development of an Artificial Intelligence (AI) Action Plan. The artificial intelligence action plan is designed to address some of the technology’s most vexing issues, such as energy constraints and potential threats to intellectual property.
The CAP comments—which were aligned with the CAP’s communications to the Trump Transition Team and Congress about key priority issues— emphasized the need for appropriate regulation of AI. An action plan must support innovation and patient safety in laboratory AI applications while maintaining the critical leadership role of pathologists in clinical decision-making, the CAP said.